bluesail+ surgical logo — Redefining Surgical Horizon

bluesail+ surgical

Redefining Surgical Horizon

Founded 2020 China Shanghai, China 14 employees Series A Total: $1.00B Biotechnology, Medical Devices

General Information

Company Name bluesail+ surgical
Founded Year 2020
Location China Shanghai, China +2
Employees 14
Industries Biotechnology, Medical Devices
Funding Stage Series A
Social

Get notified when bluesail+ surgical moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About bluesail+ surgical

Bluesail+ Surgical

Slogan: Redefining Surgical Horizon

Description: Bluesail Surgical is a minimally invasive surgery division established by the leading A-share medical device company Bluesail Medical. The company has set up 4 R&D centers, 6 production sites, and 4 clinical trial registries globally, functioning as a 24-hour R&D system with 544 researchers and more than 300 patents. Their main products include Endoscopic Staplers, Open Staplers, Trocars, Hemostatic Forcep, and Ultrasonic Scalpel, among others. Leveraging Bluesail Medical’s expertise in R&D and sales channels, Bluesail Surgical aims to excel in medium and high-value surgical consumables, striving to offer surgeons a cost-effective, top-quality surgical equipment portfolio.

Founded: 2019

Industry: Biotechnology

Headquarter: China

Last Investment: CNY100.00M Series A investment at 21 May 2024

Last Investment Investors: Daxing Linkong Development Fund

For more information, visit bluesailsurgical.com/en/

Taxonomy: Surgical Devices, Minimally Invasive Surgery, Endoscopic Staplers, Open Staplers, Trocars, Hemostatic Forcep, Ultrasonic Scalpel, Surgical Consumables, Cardiovascular Surgery, Cerebrovascular Treatments, Innovative Surgical Instruments, Global R&D System, Top Brand Surgical Instruments

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1 •••• •••• 21 May 2024
Venture Round •••••• 3
Investor
•••• ••••
25 Jan 2024

bluesail+ surgical Alternatives & Competitors

bluesail+ surgical vs

Advancing Surgical Technology to Benefit More People

6 employees
Biotechnology, Health Care
bluesail+ surgical vs

Affordable. Reliable. Precise.

37 employees
Manufacturing, Medical Devices
bluesail+ surgical vs

Wir halten Wort!

2 employees
Manufacturing, Medical Devices

FAQ About bluesail+ surgical

Redefining Surgical Horizon
bluesail+ surgical was founded in 2020.
bluesail+ surgical is headquartered in Shanghai, China.
bluesail+ surgical operates in the following industries: Biotechnology, Medical Devices.
bluesail+ surgical has approximately 14 employees.
bluesail+ surgical has completed 2 funding rounds, raising a total of $1.00B. The latest funding stage is Series A.
Top alternatives and competitors to bluesail+ surgical include Golden Stapler Surgical Co., Ltd., Rumex International Co., e.l.zepf GmbH, Tailor Surgery, BPI Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
bluesail+ surgical and Golden Stapler Surgical Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors bluesail+ surgical and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes